We want to hear from you. Tell us what you think here or leave a comment on the app's iTunes or Google Play page. Lipid Manager helps clinicians reduce ASCVD risk by managing patients' LDL-C and ...

Artificial intelligence (AI) and digital technology advances have emerged as catalysts for changing how we diagnose, treat and manage patients. The following collection of AI resources has been ...

ACC's Strategic Plan positions the College and its members for success in achieving the ACC's Mission to transform cardiovascular care and improve heart health for all as cardiovascular disease ...

Learn and stay certified — all in one program: The CMP blends continuous learning with assessment, making it an efficient, effective way to grow your expertise while maintaining your credentials.

A new ACC Scientific Statement focused on the management of atherosclerotic cardiovascular disease, aims to help clinicians overcome the perpetual challenge of balancing the risk of ischemia with the ...

The ACC is dedicated to creating a strong, diverse and inclusive field of future cardiovascular physicians, scientists and professionals. The ACC's Internal Medicine Cardiology and Pediatric Residents ...

The Board of Governors (BOG) is the College's grassroots forum. Governors are the only elected leaders in the College, and they represent their members in Canada, Mexico, the United States and Puerto ...

The Electrophysiology (EP) Section is a vibrant community for all ACC members who are interested in the evaluation and management of heart rhythm disorders. The role of the EP Leadership Council is to ...

The Centers for Medicare and Medicaid Services' (CMS') new Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) model will begin July 5, 2026. In preparation for the launch, the agency ...

When compared with liberal oxygen therapy, conservative oxygen therapy did not improve rates of survival with favorable functional outcomes among unresponsive patients in the intensive care unit (ICU) ...

In patients with atrial fibrillation (AFib) and left ventricular systolic dysfunction (LVSD), catheter ablation was associated with substantial improvement in LVEF regardless of late gadolinium ...

Survodutide led to significant weight loss in adults with obesity and without diabetes, according to results from the randomized, placebo-controlled SYNCHRONIZE-1 trial published June 7 in NEJM. This ...